Israel Discount Bank of New York’s Alexion Pharmaceuticals ALXN Stock Holding History

Israel Discount Bank of New York’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,980	Closed	-$621K	–	83
2020 Q4	$621K	Sell	3,980 -2,157	-35%	-$277K	0.45%	51
2020 Q3	$703K	Sell	6,137 -282	-4%	-$30.4K	0.46%	55
2020 Q2	$721K	Sell	6,419 -1,245	-16%	-$132K	0.49%	50
2020 Q1	$688K	Buy	7,664 +747	+11%	+$73.3K	0.53%	52
2019 Q4	$748K	Buy	6,917 +110	+2%	+$11.8K	0.49%	54
2019 Q3	$667K	Buy	6,807 +908	+15%	+$102K	0.49%	56
2019 Q2	$773K	Buy	5,899 +215	+4%	+$27.7K	0.59%	43
2019 Q1	$769K	Buy	5,684 +234	+4%	+$29.1K	0.53%	38
2018 Q4	$531K	Buy	5,450 +135	+3%	+$16K	0.41%	50
2018 Q3	$739K	Buy	5,315 +300	+6%	+$37.6K	0.48%	40
2018 Q2	$622K	Buy	5,015 +612	+14%	+$71.5K	0.41%	50
2018 Q1	$491K	Buy	4,403 +689	+19%	+$82.4K	0.33%	61
2017 Q4	$444K	Buy	3,714 +885	+31%	+$108K	0.31%	67
2017 Q3	$397K	Buy	2,829 +240	+9%	+$32.6K	0.3%	68
2017 Q2	$315K	Buy	2,589 +2,400	+1,270%	+$279K	0.25%	73
2017 Q1	$23K	Sell	189 -10	-5%	-$1.29K	0.02%	363
2016 Q4	$24K	Buy	+199	New	+$24.4K	0.02%	390

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Discount Bank of New York's ALXN Position: Q1 2021 in Review

Israel Discount Bank of New York sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 3,980 shares — an estimated $621K sold.

Israel Discount Bank of New York first reported a position in ALXN in Q4 2016 and held it in 17 quarters. The position peaked at $773K in Q2 2019. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Israel Discount Bank of New York reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Israel Discount Bank of New York sold 3,980 Alexion Pharmaceuticals shares in Q1 2021, an estimated $621K.
Israel Discount Bank of New York first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 17 quarters.
Israel Discount Bank of New York's Alexion Pharmaceuticals position peaked at $773K in Q2 2019.
753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Israel Discount Bank of New York's 13F filing for Q1 2021, filed 12 Apr 2021.